COVID-19 continues to pose a high risk to pregnant people who contract the virus. Despite this concern, hesitancy surrounding the safety of the COVID-19 vaccine during pregnancy remains, write the authors of a preprint article on COVID-19 vaccines and pregnancy outcomes. As COVID-19 vaccines become more widely available, some have raised concerns regarding potential links between receiving a COVID-19 vaccine and experiencing miscarriage (also known as spontaneous abortion), and other adverse outcomes. However, miscarriage is a common occurrence – around 10 to 15 percent of all pregnancies in the United States end in miscarriage – and multiple studies have found no increase in miscarriage in persons who received a COVID-19 vaccine.

A positive birth experience is not a luxury, but a necessity, said Hedieh Mehrtash, consultant for the Department of Sexual and Reproductive Health and Research at the World Health Organization (WHO), at a panel during the Maternal Mental Health Technical Consultation hosted by the United States Agency for International Development’s (USAID) MOMENTUM Country and Global Leadership, in collaboration with WHO and the United Nations Population Fund. 

In the United States, approximately 10 to 15 percent of known pregnancies end in miscarriage. But this doesn’t capture the full picture. In reality, studies show that as many as half of all pregnancies may end in miscarriage, with the vast majority occurring before people realize they are pregnant. A miscarriage is defined as pregnancy loss before 20 weeks gestation. While some health conditions such as autoimmune disorders, polycystic ovary syndrome (PCOS), and diabetes can exacerbate the risk of having a miscarriage, the exact causes of pregnancy loss are largely unknown.

Vaccination hesitancy, even in the midst of a global pandemic, is a major barrier to the elimination of several highly contagious and deadly diseases. While COVID-19 vaccines are getting the most attention, they are not the only vaccines that protect against deadly contagious diseases. And as with the COVID-19 vaccines, around the world, many communities are insufficiently covered by vaccines—particularly children. This is especially true in West Africa, where—though improving—childhood immunization rates still lag behind much of the world. To explore reasons for these persistent low childhood immunization rates, Breakthrough RESEARCH, a USAID-funded project that works to expand the evidence base for social and behavior change programming, increase healthy behaviors, and enable positive social norms through improved social and behavior change programming, conducted a study to look at behavioral drivers of decision-making about vaccines in Nigeria.

Whether marginalized populations, such as adolescents, LGBTQ+ people, migrant workers, and sex workers are included in health services can be a “litmus test” of our progress towards universal health coverage (UHC), said Sivananthi Thanenthiran, Executive Director of Asian-Pacific Resource and Research Centre for Women (ARROW). Thanenthiran spoke at a recent Wilson Center event with the United Nations Population Fund (UNFPA) and the World Health Organization (WHO) Department of Sexual and Reproductive Health and Research about the importance of engaging stakeholders in sexual and reproductive health (SRH) to achieve UHC for all. In SRH services, the most marginalized and most vulnerable populations are often left out, she said. When engaging stakeholders, representatives from these groups must be included to ensure equity in healthcare services.